Tandem Diabetes Care is expanding its Control-IQ+ automated insulin delivery system to work with Abbott’s newest 15-day continuous glucose monitor in five European countries, with three more markets planned later this year.
Tandem Diabetes Care is expanding its Control-IQ+ automated insulin delivery system to pair with Abbott's newest 15-day continuous glucose monitor in the United Kingdom, Switzerland, Sweden, Finland and Italy. Belgium, the Netherlands and Germany are expected to follow later this year as part of the broader rollout.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.